BreachOfPrivacy
Decisions/Federal (Canada)/Privacy Act/Public disclosure of medical information during military trial consistent with Privacy Act
Office of the Privacy Commissioner of CanadaPrivacy ActNot well-founded
Flag of Canada

Public disclosure of medical information during military trial consistent with Privacy Act

Organization: Department of National Defence (DND)Complainant: A former member of the military
Decision: Jan 15, 2020Published: Jan 15, 2020

A former member of the Canadian Armed Forces complained that the Department of National Defence (DND) wrongfully compelled him to publicly disclose medical information during a military summary trial. The Office of the Privacy Commissioner of Canada (OPC) found the complaint was not well-founded. The OPC determined that the disclosure was made as testimony during a public military trial, consistent with the open courts principle and the National Defence Act. Since confidentiality was not requested, the disclosure was permitted under subsections 8(2)(a) and 8(2)(b) of the Privacy Act.

  • Applicability of the Privacy Act to military summary trials
  • Whether public disclosure of medical information during a summary trial contravened the Privacy Act
  • The principle of open courts in military justice proceedings
  • The concept of publicly available information under section 69 of the Privacy Act

Complaint not well-founded

The disclosure of the complainant's medical information during the military summary trial was considered a necessary part of the trial proceedings under the National Defence Act and consistent with the open courts principle. As confidentiality was not requested and the information was provided in a public forum, the disclosure was permitted under the Privacy Act.

AI-generated summary for reference only. Always verify against the official decision ↗

Statutory provisions cited
  • s. 8(2)(a) Privacy Act
  • s. 8(2)(b) Privacy Act
  • s. 69(2) Privacy Act
  • National Defence Act

This summary is informational only and not legal advice.